BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 35113235)

  • 1. Radiotherapy resistance: identifying universal biomarkers for various human cancers.
    Larionova I; Rakina M; Ivanyuk E; Trushchuk Y; Chernyshova A; Denisov E
    J Cancer Res Clin Oncol; 2022 May; 148(5):1015-1031. PubMed ID: 35113235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor suppressor miR-29c regulates radioresistance in lung cancer cells.
    Arechaga-Ocampo E; Lopez-Camarillo C; Villegas-Sepulveda N; Gonzalez-De la Rosa CH; Perez-Añorve IX; Roldan-Perez R; Flores-Perez A; Peña-Curiel O; Angeles-Zaragoza O; Rangel Corona R; Gonzalez-Barrios JA; Bonilla-Moreno R; Del Moral-Hernandez O; Herrera LA; Garcia-Carranca A
    Tumour Biol; 2017 Mar; 39(3):1010428317695010. PubMed ID: 28345453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Network-based analysis of prostate cancer cell lines reveals novel marker gene candidates associated with radioresistance and patient relapse.
    Seifert M; Peitzsch C; Gorodetska I; Börner C; Klink B; Dubrovska A
    PLoS Comput Biol; 2019 Nov; 15(11):e1007460. PubMed ID: 31682594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RPA3 is a potential marker of prognosis and radioresistance for nasopharyngeal carcinoma.
    Qu C; Zhao Y; Feng G; Chen C; Tao Y; Zhou S; Liu S; Chang H; Zeng M; Xia Y
    J Cell Mol Med; 2017 Nov; 21(11):2872-2883. PubMed ID: 28557284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomics discovery of radioresistant cancer biomarkers for radiotherapy.
    Chang L; Graham P; Hao J; Bucci J; Malouf D; Gillatt D; Li Y
    Cancer Lett; 2015 Dec; 369(2):289-97. PubMed ID: 26427840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic Profiling Identifies PTK2/FAK as a Driver of Radioresistance in HPV-negative Head and Neck Cancer.
    Skinner HD; Giri U; Yang L; Woo SH; Story MD; Pickering CR; Byers LA; Williams MD; El-Naggar A; Wang J; Diao L; Shen L; Fan YH; Molkentine DP; Beadle BM; Meyn RE; Myers JN; Heymach JV
    Clin Cancer Res; 2016 Sep; 22(18):4643-50. PubMed ID: 27036135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic signature associated with radioresistance in head and neck cancer via transcriptomic and bioinformatic analyses.
    You GR; Cheng AJ; Lee LY; Huang YC; Liu H; Chen YJ; Chang JT
    BMC Cancer; 2019 Jan; 19(1):64. PubMed ID: 30642292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Micro-RNAs, the Cornerstones of the Future of Radiobiology in Head and Neck Cancers?
    Mireștean CC; Iancu RI; Iancu DPT
    Curr Oncol; 2022 Feb; 29(2):816-833. PubMed ID: 35200568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Identification of predictive biomarkers to radiotherapy outcome through proteomics approaches].
    Lacombe J; Mange A; Azria D; Solassol J
    Cancer Radiother; 2013 Feb; 17(1):62-9; quiz 70, 72. PubMed ID: 23287796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNAs Involvement in Radioresistance of Head and Neck Cancer.
    Ahmad P; Sana J; Slavik M; Slampa P; Smilek P; Slaby O
    Dis Markers; 2017; 2017():8245345. PubMed ID: 28325958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EphA3 maintains radioresistance in head and neck cancers through epithelial mesenchymal transition.
    Kim SH; Lee WH; Kim SW; Je HU; Lee JC; Chang HW; Kim YM; Kim K; Kim SY; Han MW
    Cell Signal; 2018 Jul; 47():122-130. PubMed ID: 29653204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiotherapy diagnostic biomarkers in radioresistant human H460 lung cancer stem-like cells.
    Yun HS; Baek JH; Yim JH; Um HD; Park JK; Song JY; Park IC; Kim JS; Lee SJ; Lee CW; Hwang SG
    Cancer Biol Ther; 2016; 17(2):208-18. PubMed ID: 26901847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KLK5 is associated with the radioresistance, aggression, and progression of cervical cancer.
    Zhou S; Liu S; Tian G; Zhao L; Wang H; Li Y; Shen Y; Han L
    Gynecol Oncol; 2022 Jul; 166(1):138-147. PubMed ID: 35595569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD59 is a potential biomarker of esophageal squamous cell carcinoma radioresistance by affecting DNA repair.
    Zhou Y; Chu L; Wang Q; Dai W; Zhang X; Chen J; Li L; Ding P; Zhang L; Gu H; Li L; Lv X; Zhang W; Zhou D; Zhang P; Cai G; Zhao K; Hu W
    Cell Death Dis; 2018 Aug; 9(9):887. PubMed ID: 30166523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-wide RNAi Screening Identifies RFC4 as a Factor That Mediates Radioresistance in Colorectal Cancer by Facilitating Nonhomologous End Joining Repair.
    Wang XC; Yue X; Zhang RX; Liu TY; Pan ZZ; Yang MJ; Lu ZH; Wang ZY; Peng JH; Le LY; Wang GY; Peng QH; Meng Y; Huang W; Liu RY
    Clin Cancer Res; 2019 Jul; 25(14):4567-4579. PubMed ID: 30979744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of Non-coding RNAs in Chemo- and Radioresistance of Colorectal Cancer.
    Fanale D; Castiglia M; Bazan V; Russo A
    Adv Exp Med Biol; 2016; 937():207-28. PubMed ID: 27573902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic amplification of Fanconi anemia complementation group A (FancA) in head and neck squamous cell carcinoma (HNSCC): Cellular mechanisms of radioresistance and clinical relevance.
    Hess J; Unger K; Orth M; Schötz U; Schüttrumpf L; Zangen V; Gimenez-Aznar I; Michna A; Schneider L; Stamp R; Selmansberger M; Braselmann H; Hieber L; Drexler GA; Kuger S; Klein D; Jendrossek V; Friedl AA; Belka C; Zitzelsberger H; Lauber K
    Cancer Lett; 2017 Feb; 386():87-99. PubMed ID: 27867017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted Proteomic Analysis Revealed Kinome Reprogramming during Acquisition of Radioresistance in Breast Cancer Cells.
    Miao W; Bade D; Wang Y
    J Proteome Res; 2021 May; 20(5):2830-2838. PubMed ID: 33739118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomic identification of putative biomarkers of radiotherapy resistance: a possible role for the 26S proteasome?
    Smith L; Qutob O; Watson MB; Beavis AW; Potts D; Welham KJ; Garimella V; Lind MJ; Drew PJ; Cawkwell L
    Neoplasia; 2009 Nov; 11(11):1194-207. PubMed ID: 19881955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SMC1A is associated with radioresistance in prostate cancer and acts by regulating epithelial-mesenchymal transition and cancer stem-like properties.
    Yadav S; Kowolik CM; Lin M; Zuro D; Hui SK; Riggs AD; Horne DA
    Mol Carcinog; 2019 Jan; 58(1):113-125. PubMed ID: 30242889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.